Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMDP) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for LifeMD (LFMDP) over the last 6 years, with Q3 2025 value amounting to $2.8 million.

  • LifeMD's Capital Expenditures fell 809.6% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year increase of 1334.06%. This contributed to the annual value of $10.0 million for FY2024, which is 1982.03% up from last year.
  • As of Q3 2025, LifeMD's Capital Expenditures stood at $2.8 million, which was down 809.6% from $2.9 million recorded in Q2 2025.
  • LifeMD's 5-year Capital Expenditures high stood at $3.0 million for Q3 2024, and its period low was $48860.0 during Q1 2021.
  • Moreover, its 5-year median value for Capital Expenditures was $2.1 million (2023), whereas its average is $2.0 million.
  • Per our database at Business Quant, LifeMD's Capital Expenditures plummeted by 2856.73% in 2021 and then surged by 419419.36% in 2022.
  • LifeMD's Capital Expenditures (Quarter) stood at $1.4 million in 2021, then grew by 27.27% to $1.8 million in 2022, then grew by 18.17% to $2.1 million in 2023, then increased by 18.41% to $2.5 million in 2024, then increased by 12.1% to $2.8 million in 2025.
  • Its last three reported values are $2.8 million in Q3 2025, $2.9 million for Q2 2025, and $2.7 million during Q1 2025.